Advertisement
Advertisement
U.S. markets close in 5 hours 6 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Metacrine, Inc. (MTCR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3999+0.0125 (+3.23%)
As of 10:51AM EST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Metacrine Reports Third-Quarter 2022 Results

    SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company developing differentiated therapies for patients with gastrointestinal diseases, today reported its third-quarter 2022 financial results. “We made great progress during the quarter in advancing our proposed merger with Equillium,” said Preston Klassen, M.D., MHS, president and chief executive officer of Metacrine. “We believe that Equillium has demonstrated compelling clinical d

  • Benzinga

    Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal

    Equillium Inc (NASDAQ: EQ) has agreed to acquire Metacrine Inc (NASDAQ: MTCR) in an all-stock transaction. The transaction is anticipated to add $33 million in cash to Equillium's balance sheet at closing, which is expected to extend the company's cash runway into 2024. Earlier this year, Metacrine axed 50% of its workforce. Through the acquisition, Equillium adds Metacrine's farnesoid X receptor platform, including lead molecule MET642 for inflammatory bowel diseases. Equillium will be seeking

  • Business Wire

    Equillium to Acquire Metacrine in All-Stock Transaction

    LA JOLLA, Calif., September 06, 2022--Equillium, Inc. (Nasdaq: EQ) and Metacrine Inc. (Nasdaq: MTCR), today announced that the two companies have entered into a definitive merger agreement pursuant to which Equillium will acquire Metacrine in an all-stock transaction. The transaction is anticipated to add $33 million in cash to Equillium’s balance sheet at closing, which is expected to extend the company’s cash runway into 2024. The transaction has been approved by the boards of directors of bot

Advertisement
Advertisement